Literature DB >> 22231866

Muscle imaging findings in GNE myopathy.

Giorgio Tasca1, Enzo Ricci, Mauro Monforte, Francesco Laschena, Pierfrancesco Ottaviani, Carmelo Rodolico, Emanuele Barca, Gabriella Silvestri, Elisabetta Iannaccone, Massimiliano Mirabella, Aldobrando Broccolini.   

Abstract

GNE myopathy (MIM 600737) is an autosomal recessive muscle disease caused by mutations in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene. Besides the typical phenotype, characterized by the initial involvement of the distal leg muscles that eventually spreads proximally with sparing of the quadriceps, uncommon presentations with a non-canonical clinical phenotype, unusual muscle biopsy findings or both are increasingly recognized. The aim of our study was to characterize the imaging pattern of pelvic and lower limb muscles in GNE myopathy, thus providing additional diagnostic clues useful in the identification of patients with atypical features. We retrospectively evaluated muscle MRI and CT scans of a cohort of 13 patients heterogeneous for GNE mutations and degree of clinical severity. We found that severe involvement of the biceps femoris short head and, to a lesser extent, of the gluteus minimus, tibialis anterior, extensor hallucis and digitorum longus, soleus and gastrocnemius medialis was consistently present even in patients with early or atypical disease. The vastus lateralis, not the entire quadriceps, was the only muscle spared in advanced stages, while the rectus femoris, vastus intermedius and medialis showed variable signs of fatty replacement. Younger patients showed hyperintensities on T2-weighted sequences in muscles with a normal or, more often, abnormal T1-weighted signal. Our results define a pattern of muscle involvement that appears peculiar to GNE myopathy. Although these findings need to be further validated in a larger cohort, we believe that the recognition of this pattern may be instrumental in the initial clinical assessment of patients with possible GNE myopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231866     DOI: 10.1007/s00415-011-6357-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene.

Authors:  A Broccolini; M Pescatori; A D'Amico; A Sabino; G Silvestri; E Ricci; S Servidei; P A Tonali; M Mirabella
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

2.  A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation.

Authors:  Sabine Krause; Beate Schlotter-Weigel; Maggie C Walter; Hossein Najmabadi; Heinz Wiendl; Josef Müller-Höcker; Wolfgang Müller-Felber; Dieter Pongratz; Hanns Lochmüller
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

3.  A novel mutation in the GNE gene and a linkage disequilibrium in Japanese pedigrees.

Authors:  Aki Arai; Keiko Tanaka; Takeshi Ikeuchi; Shuichi Igarashi; Hisashi Kobayashi; Tomoya Asaka; Hidetoshi Date; Masaaki Saito; Hajime Tanaka; Sari Kawasaki; Eiichiro Uyama; Hidehiro Mizusawa; Nobuyoshi Fukuhara; Shoji Tsuji
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

4.  Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy.

Authors:  A Broccolini; T Gidaro; G Tasca; R Morosetti; C Rodolico; E Ricci; M Mirabella
Journal:  Neurology       Date:  2010-07-20       Impact factor: 9.910

5.  GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM.

Authors:  Olavo M Vasconcelos; Raghavan Raju; Marinos C Dalakas
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

6.  Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.

Authors:  Heinz Jungbluth; Mark R Davis; Clemens Müller; Serena Counsell; Joanna Allsop; Arijit Chattopadhyay; Sonia Messina; Eugenio Mercuri; Nigel G Laing; Caroline A Sewry; Graeme Bydder; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2004-12       Impact factor: 4.296

7.  NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations.

Authors:  E Ricci; A Broccolini; T Gidaro; R Morosetti; C Gliubizzi; R Frusciante; G M Di Lella; P A Tonali; M Mirabella
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

8.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.

Authors:  Peter Hackman; Anna Vihola; Henna Haravuori; Sylvie Marchand; Jaakko Sarparanta; Jerome De Seze; Siegfried Labeit; Christian Witt; Leena Peltonen; Isabelle Richard; Bjarne Udd
Journal:  Am J Hum Genet       Date:  2002-07-26       Impact factor: 11.025

9.  Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene.

Authors:  K G Claeys; M Fardeau; R Schröder; T Suominen; K Tolksdorf; A Behin; O Dubourg; B Eymard; T Maisonobe; T Stojkovic; G Faulkner; P Richard; P Vicart; B Udd; T Voit; G Stoltenburg
Journal:  Neuromuscul Disord       Date:  2008-07-23       Impact factor: 4.296

10.  Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.

Authors:  K Kesper; C Kornblum; J Reimann; G Lutterbey; R Schröder; M P Wattjes
Journal:  Acta Neurol Scand       Date:  2008-12-22       Impact factor: 3.209

View more
  20 in total

1.  Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy.

Authors:  Teresa Gidaro; Harmen Reyngoudt; Julien Le Louër; Anthony Behin; Ferial Toumi; Melanie Villeret; Ericky C A Araujo; Pierre-Yves Baudin; Benjamin Marty; Melanie Annoussamy; Jean-Yves Hogrel; Pierre G Carlier; Laurent Servais
Journal:  J Neurol       Date:  2019-10-15       Impact factor: 4.849

2.  Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.

Authors:  Marco Savarese; Lorenzo Maggi; Anna Vihola; Per Harald Jonson; Giorgio Tasca; Lucia Ruggiero; Luca Bello; Francesca Magri; Teresa Giugliano; Annalaura Torella; Anni Evilä; Giuseppina Di Fruscio; Olivier Vanakker; Sara Gibertini; Liliana Vercelli; Alessandra Ruggieri; Carlo Antozzi; Helena Luque; Sandra Janssens; Maria Barbara Pasanisi; Chiara Fiorillo; Monika Raimondi; Manuela Ergoli; Luisa Politano; Claudio Bruno; Anna Rubegni; Marika Pane; Filippo M Santorelli; Carlo Minetti; Corrado Angelini; Jan De Bleecker; Maurizio Moggio; Tiziana Mongini; Giacomo Pietro Comi; Lucio Santoro; Eugenio Mercuri; Elena Pegoraro; Marina Mora; Peter Hackman; Bjarne Udd; Vincenzo Nigro
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

3.  Atypical presentation of GNE myopathy with asymmetric hand weakness.

Authors:  John Karl L de Dios; Joseph A Shrader; Galen O Joe; Jeffrey C McClean; Kayla Williams; Robert Evers; May Christine V Malicdan; Carla Ciccone; Ami Mankodi; Marjan Huizing; John C McKew; David A Bluemke; William A Gahl; Nuria Carrillo-Carrasco
Journal:  Neuromuscul Disord       Date:  2014-08-07       Impact factor: 4.296

Review 4.  Mutation update for GNE gene variants associated with GNE myopathy.

Authors:  Frank V Celeste; Thierry Vilboux; Carla Ciccone; John Karl de Dios; May Christine V Malicdan; Petcharat Leoyklang; John C McKew; William A Gahl; Nuria Carrillo-Carrasco; Marjan Huizing
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

5.  Neuromyopathy with congenital cataracts and glaucoma: a distinct syndrome caused by POLG variants.

Authors:  Claudia Castiglioni; Fabiana Fattori; Bjarne Udd; Maria de Los Angeles Avaria; Bernardita Suarez; Adele D'Amico; Alessandro Malandrini; Rosalba Carrozzo; Daniela Verrigni; Enrico Bertini; Giorgio Tasca
Journal:  Eur J Hum Genet       Date:  2018-01-22       Impact factor: 4.246

6.  Relationship between markers of disease activity and progression in skeletal muscle of GNE myopathy patients using quantitative nuclear magnetic resonance imaging and 31P nuclear magnetic resonance spectroscopy.

Authors:  Harmen Reyngoudt; Benjamin Marty; Ericky Caldas de Almeida Araújo; Pierre-Yves Baudin; Julien Le Louër; Jean-Marc Boisserie; Anthony Béhin; Laurent Servais; Teresa Gidaro; Pierre G Carlier
Journal:  Quant Imaging Med Surg       Date:  2020-07

Review 7.  GNE myopathy: current update and future therapy.

Authors:  Ichizo Nishino; Nuria Carrillo-Carrasco; Zohar Argov
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-07       Impact factor: 10.154

8.  Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in β1-integrin-mediated cell adhesion.

Authors:  Sonam Grover; Ranjana Arya
Journal:  Mol Neurobiol       Date:  2014-01-29       Impact factor: 5.590

Review 9.  GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.

Authors:  Nuria Carrillo; May C Malicdan; Marjan Huizing
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy.

Authors:  Chia-Ying Liu; Jianhua Yao; William C Kovacs; Joseph A Shrader; Galen Joe; Ronald Ouwerkerk; Ami K Mankodi; William A Gahl; Ronald M Summers; Nuria Carrillo
Journal:  Neurology       Date:  2020-11-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.